🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
73.01
-4.66 (-6.00%)
At close: Nov 20, 2026, 4:00 PM EST
72.85
-0.16 (-0.22%)
After-hours: Nov 20, 2026, 6:09 PM EST

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had revenue of $194.57M in the quarter ending September 30, 2026, with 63.92% growth. This brings the company's total for the last twelve months to $682.20M, up 86.34% year-over-year. In the year 2025, Tarsus Pharmaceuticals had annual revenue of $451.36M with 146.71% growth. That makes Tarsus Pharmaceuticals the 9,544th largest company in the world by revenue and 2,081st in the United States.

Revenue (ttm)
$682.20M
Revenue Growth
+86.34%
P/S Ratio
5.27
Revenue / Employee
$1,843,792
Employees
370
Market Cap
3.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025451.36M268.41M146.71%
Dec 31, 2024182.95M165.51M948.62%
Dec 31, 202317.45M-8.37M-32.42%
Dec 31, 202225.82M-31.21M-54.73%
Dec 31, 202157.03M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.